BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19212678)

  • 1. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
    Ulasov IV; Tyler MA; Zhu ZB; Han Y; He TC; Lesniak MS
    Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
    Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
    Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
    Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.
    Kaverina NV; Kadagidze ZG; Borovjagin AV; Karseladze AI; Kim CK; Lesniak MS; Miska J; Zhang P; Baryshnikova MA; Xiao T; Ornelles D; Cobbs C; Khramtsov A; Ulasov IV
    Oncogene; 2018 Nov; 37(46):6069-6082. PubMed ID: 29991800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
    Tong Y; You L; Liu H; Li L; Meng H; Qian Q; Qian W
    Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV; Sonabend AM; Nandi S; Khramtsov A; Han Y; Lesniak MS
    Br J Cancer; 2009 Apr; 100(7):1154-64. PubMed ID: 19277041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.
    Nandi S; Ulasov IV; Rolle CE; Han Y; Lesniak MS
    J Gene Med; 2009 Nov; 11(11):1005-11. PubMed ID: 19688792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
    Nandi S; Ulasov IV; Tyler MA; Sugihara AQ; Molinero L; Han Y; Zhu ZB; Lesniak MS
    Cancer Res; 2008 Jul; 68(14):5778-84. PubMed ID: 18632631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
    Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS
    Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
    Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
    J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
    Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis.
    Niu TK; Cheng Y; Ren X; Yang JM
    FEBS Lett; 2010 Aug; 584(16):3519-24. PubMed ID: 20638385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses, gene therapy and stem cells for the treatment of human glioma.
    Kyritsis AP; Sioka C; Rao JS
    Cancer Gene Ther; 2009 Oct; 16(10):741-52. PubMed ID: 19644531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues.
    Yamamoto Y; Hiraoka N; Goto N; Rin Y; Miura K; Narumi K; Uchida H; Tagawa M; Aoki K
    J Control Release; 2014 Oct; 192():284-93. PubMed ID: 25108153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
    Zhu ZB; Makhija SK; Lu B; Wang M; Rivera AA; Kim-Park S; Ulasov IV; Zhou F; Alvarez RD; Siegal GP; Curiel DT
    Int J Oncol; 2005 Jul; 27(1):237-46. PubMed ID: 15942665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of Beclin 1 enhances apoptosis by H2O2 in glioma U251 cells].
    Kong XX; Zhang HY; Chen ZQ; Fan XF; Gong YS
    Sheng Li Xue Bao; 2011 Jun; 63(3):238-44. PubMed ID: 21681342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C; Fueyo J
    Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.
    Zhu ZB; Makhija SK; Lu B; Wang M; Wang S; Takayama K; Siegal GP; Reynolds PN; Curiel DT
    J Thorac Oncol; 2006 Sep; 1(7):701-11. PubMed ID: 17409940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.